HomeSotalol

Sotalol

Check Sotalol Interactions →
15 interactions on record

Sotalol has 15 known drug interactions based on U.S. FDA drug labeling data. Of these, 2 are contraindicated combinations that should be avoided entirely. 10 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Macimorelin Acetate, Pimozide, Clarithromycin. Patients taking Sotalol should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total
15
Contraindicated
2
Major
10
Moderate
3

Contraindicated (2)

  • Sotalol + Macimorelin AcetateCo-administration may lead to torsade de pointes-type ventricular tachycardia due to QT prolongation. Avoid concomitant
  • Sotalol + PimozideAdditive QT interval prolongation effect anticipated, increasing risk of ventricular arrhythmias.

Major (10)

  • Sotalol + ClarithromycinAntiarrhythmic affected by clarithromycin CYP3A inhibition. Risk of QTc prolongation and torsades de pointes.
  • Sotalol + DigoxinProarrhythmic events more common with concurrent use. Increased risk of arrhythmias with concomitant administration.
  • Sotalol + EtrasimodClass III anti-arrhythmic drug that may increase risk of QT prolongation and Torsades de Pointes due to additive effects
  • Sotalol + Foscarnet SodiumShould be avoided due to risk of QT prolongation and torsades de pointes.
  • Sotalol + Moxifloxacin HydrochlorideClass III antiarrhythmic that may further increase QTc interval when combined with moxifloxacin, with proarrhythmic effe
  • Sotalol + Ozanimod HydrochlorideClass III anti-arrhythmic; associated with Torsades de Pointes in bradycardia patients. Cardiologist advice recommended
  • Sotalol + PonesimodClass III anti-arrhythmic drug associated with Torsades de Pointes in bradycardic patients; should generally not be init
  • Sotalol + SiponimodClass III antiarrhythmic associated with Torsades de Pointes in bradycardia patients; should generally not be initiated
  • Sotalol + TetrabenazineClass III antiarrhythmic that prolongs QTc interval. Concomitant use should be avoided due to additive QTc prolongation
  • Sotalol + Toremifene CitrateClass III antiarrhythmic that prolongs QT interval; should be avoided with toremifene citrate or requires close monitori

Moderate (3)

  • Sotalol + Haloperidol DecanoateClass 3 antiarrhythmic known to prolong QTc interval; caution advised when used with haloperidol decanoate due to risk o
  • Sotalol + Haloperidol LactateClass 3 antiarrhythmic that prolongs QTc interval; caution advised when used with haloperidol due to risk of QT prolonga
  • Sotalol + Lidocaine And PrilocaineClass III antiarrhythmic drug; specific interaction studies not performed but caution is advised when used with lidocain

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.